target validation

Brioche is a research desk and molecular design layer for precision medicine and drug development teams. It reads the public regulatory, clinical, patent, and deal record and writes it back as decision-grade analysis, cited to primary sources with retrieval timestamps and signed by a named reviewer. Its Discovery Engine is modality- and indication-agnostic, covering small molecules, biologics, peptides, ASOs, and nucleic-acid therapies.

analog designaudit-trail retentioncompetitive landscape analysisdeal diligencemolecular designnovel molecular designregulatory intelligence

Cureline, Inc. is a global translational and precision medicine CRO and human biospecimen biobank, originated in the San Francisco Bay area (California, USA) in 2003. It provides biobanking and laboratory services for drug R&D and diagnostics development, with a biorepository holding 50,000-100,000 specimens and a clinical network of 150+ partners in 20 countries.

biobankingbiomarker discovery and validationbiorepositorydigital pathologyglycoproteomicshistopathologymolecular analysisspecimen collectiontissue microarray

Cytoskeleton, Inc. is a supplier of advanced cell biology and protein products, offering user-friendly kits, specialty reagents, and custom services. Since 1994 it has been involved in small G-protein research, launching the first line of small GTPase reagents in consultation with Dr. Alan Hall. The company provides products with over 50,000 product citations and 30+ years serving the scientific community.

assay developmentcompound screeningcustom servicesprotein purification